TIFA
TRAF-interacting protein with FHA domain-containing protein A
Also known as: MGC20791, T2BP, T6BP, TIFA_HUMAN, TIFAA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96CG3
- Gene
- TIFA
- Ensembl
- ENSG00000145365
- Chromosome
- 4
- Canonical length
- 184 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes an adapter protein involved in adaptive and innate immunity. This protein includes a forkhead-associated (FHA) domain that specifically binds to phosphorylated serine and threonine residues. In response to bacterial infection, the encoded host cell protein undergoes an intermolecular interaction between the FHA domain and a phosphorylated threonine that leads to protein oligomerization and stimulation of the NF-kappa B and other downstream signaling pathways. This protein exhibits reduced expression in hepatocellular carcinoma and may suppress hepatocellular carcinoma progression. This protein may also play a role in the DNA damage response. [provided by RefSeq, Jun 2018]
Canonical amino-acid sequenceUniProt
184 residues, UniProt reviewed canonical sequence.
>Q96CG3|TIFA
1 MTSFEDADTE ETVTCLQMTV YHPGQLQCGI FQSISFNREK LPSSEVVKFG RNSNICHYTF
61 QDKQVSRVQF SLQLFKKFNS SVLSFEIKNM SKKTNLIVDS RELGYLNKMD LPYRCMVRFG
121 EYQFLMEKED GESLEFFETQ FILSPRSLLQ ENNWPPHRPI PEYGTYSLCS SQSSSPTEMD
181 ENESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TIFA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 39 nTPM
- bone marrow: 38 nTPM
- salivary gland: 33 nTPM
- tonsil: 32 nTPM
- lymph node: 30 nTPM
- thyroid gland: 20 nTPM
Single-cell type
- pancreatic acinar cells: 131 nCPM
- esophageal apical cells: 128 nCPM
- plasma cells: 121 nCPM
- syncytiotrophoblasts: 121 nCPM
- epididymal basal cells: 74 nCPM
- salivary acinar cells: 72 nCPM
Immune cell
- naive B-cell: 41 nTPM
- memory B-cell: 38 nTPM
- T-reg: 34 nTPM
- neutrophil: 22 nTPM
- memory CD4 T-cell: 20 nTPM
- memory CD8 T-cell: 19 nTPM
Brain region
- choroid plexus: 7.9 nTPM
- cerebellum: 7.7 nTPM
- pons: 4.2 nTPM
- thalamus: 3.9 nTPM
- hypothalamus: 3.8 nTPM
- hippocampal formation: 3.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 0.89
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cytoplasmic pattern recognition receptor signaling pathway
- innate immune response
- positive regulation of canonical NF-kappaB signal transduction
- protein homooligomerization
- tumor necrosis factor-mediated signaling pathway
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TIFA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TIFA as an antibody target. Whether an autoantibody or antibody against TIFA could matter depends on whether native TIFA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TIFA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TIFA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...